Keto diet may supercharge cancer immunotherapy, early trial hints
NCT ID NCT07564219
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether raising blood levels of a natural molecule called beta-hydroxybutyrate (BHB) — through a strict ketogenic diet or ketone drinks — is safe and can improve the effectiveness of immunotherapy (CAR-T cells or bispecific antibodies) in 45 adults with multiple myeloma. Participants are randomly assigned to one of four intervention groups or a control group for 28 days. The goal is to see if this metabolic boost can enhance T-cell function without causing severe side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ketogenic diet and ketone monoester supplements
What this could lead to
If successful, this could show that raising BHB levels safely enhances T-cell function, potentially improving outcomes for multiple myeloma patients on immunotherapy.
What could go wrong
This is an early, small study (45 participants) testing feasibility and safety, not efficacy. The diet or supplements may be hard to tolerate, and results may not lead to better cancer control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University Medical Center Hamburg-Eppendorf
RECRUITINGHamburg, Free and Hanseatic City of Hamburg, 20251, Germany
Contact Email: •••••@•••••